Regulatory
Clinical trial activities are growing rapidly and dynamically, and we are currently seeking a full-time, Clinical Trials Regulatory Submissions Manager to join our Local Regulatory in Amgen Korea. This position plays a key role in the clinical trial application management, import licenses and regulatory agency inspections at Amgen.
The Clinical Trials Regulatory Submission Manager is responsible for the overall submission strategy definition including interactions with Health Authority, compiling submission dossier, execution and management of all regulatory activities for clinical trial projects and programs, according to local regulations and Amgen’s policy.
This position interacts directly with International Regulatory Team, CMC Global Product Leads, Clinical Project Management (Local Trial Managers) etc. and collaborates with Regional and Global Study Operations (GSO) teams, Pharmacovigilance, Clinical Supply Chain, Global Study Operations and Functional Service Providers to support local planning and execution for clinical studies in accordance with national legal and regulatory requirements.
Responsibilities Summary
• Efficiently end-to-end manages Clinical Trials Regulatory submission in Korea for new and ongoing project(s) or programs, including and not limited to initial applications, clinical protocol amendments, ICF amendments, quality (CMC) amendments, study periodic reporting, until the project is officially closed.
• Develops, with the input of importer of record, study specific import licenses approvals and keeps it updated.
• Monitors efficiency, quality and adherence to project timelines, SOPs and local regulations.
• Attends to regulatory inspections and corporate audits, representing the RA function.
• Communicates overall regulatory status to internal teams and service providers.
• Attends to project meetings with cross functional department leads to provide strategy, timelines and requirements for regulatory submissions and approvals.
• Works with internal team members to establish and clarify regulatory requirements
• Responsible for clinical trial regulatory intelligence, including regular updates to databases.
• Coordinate with local and global team CTA pre-submission meetings with Agency, if needed.
• Where applicable, provides work instructions to related team members in preparation of regulatory submissions, timeline estimations, issues resolution, etc.
• Collaborate with the regional or local study team (e.g. Start-up Associates, Project Managers, Regulatory Affairs, Vendors, and Contracts Department) during the total duration of study, closely monitoring to ensure regulatory milestones are met.
• Escalates issues to leadership, including plans for addressing/mitigating risks/gaps.
• Work with and oversight the in-country Functional Service Provider (FSP), ensuring that the FSP delivers per contract as well as the timelines and quality of all regulatory and safety filings.
Minimum Qualifications
• Bachelor’s in Pharmacy or equivalent in a health-related field plus 6-7 years of clinical trials experience
o within the total years of experience, at least 3-4 years of regulatory submissions experience is required
o Strong technical knowledge and 3-4 years of experience in executing Clinical Trial Applications in Korea
o (preferred) Experience in preparing, attending and responding to GCP Inspection
Knowledge and Soft Skills
• Good written and verbal communication skills in English;
• Degree and in-depth regulatory experience and/or related to the country.
• Depth knowledge of country legislation and regulations relating to medicinal products.
• Ability to conceptualize, develop and manage timelines, including its updates;
• Ability to delegate and make decisions, including risk-based ones;
• Ability to manage multiple projects and priorities;
• Ability to develop and maintain productive relationships with coworkers, managers and
service providers.
• Ability to work independently and asynchronously with different time zones within a
matrixial project team environment.

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes.
For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads.
🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines
🔗Global Privacy Statement Directory: www.amgen.com/dp
Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.